Skip to main content
Clinical Trials/JPRN-UMIN000003723
JPRN-UMIN000003723
Recruiting
未知

Investigation of influence of genetic polymorphisms of drug metabolizing enzymes and transporters, including SLCO1B3 and ABCC2, on Docetaxel Pharmacokinetics in advanced Non Small Cell Lung Cancer Patients - influence of polymorphisms of drug metabolizing enzymes and transporters on Docetaxel Pharmacokinetics

Research institute for diseases of the chest, Kyushu University0 sites50 target enrollmentJune 7, 2010

Overview

Phase
未知
Intervention
Not specified
Conditions
on-Small Cell Lung Cancer
Sponsor
Research institute for diseases of the chest, Kyushu University
Enrollment
50
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 7, 2010
End Date
July 1, 2012
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Research institute for diseases of the chest, Kyushu University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)History of poorly controlled pleural effusion, pericardial effusion and ascites. 2\)Active infection 3\)Previous severe drug allergy 4\)Hoped to be pregnant/nursing. 5\)Symptomatic brain metastasis 6\)Active concomitant malignancy 7\)History of poorly controlled diabetes mellitus 8\)History of severe complicating disease 9\)simultaneous use of other anti\-cancer drugs 10\)Those judged to be not suitable by the attending physician 11\)History of bone\-marrow transplantation 12\)Those who received a white blood cell transfusion within 30 days before registration

Outcomes

Primary Outcomes

Not specified

Similar Trials